{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:10:44Z","timestamp":1790644244567,"version":"4.1.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Drug-induced acute kidney injury (AKI) can occur both in primary care (i.e., community-acquired AKI (CA-AKI)) and in hospital settings (i.e., hospital-acquired AKI (HA-AKI)). The reported prevalence of these events varies markedly from one study to another, mainly due to differences in the study design. To estimate the frequency of drug-induced AKIs (both CA-AKIs and HA-AKIs) observed in a French university hospital, we applied the capture-recapture method to 1) the French national pharmacovigilance database (FPVD) and 2) a cohort of hospitalized patients with drug-induced AKIs (documented by analyzing the French national hospital discharge database and the patients\u2019 electronic medical records). Drug-induced AKIs were determined according to the Naranjo algorithm and then categorized as CA-AKIs or HA-AKIs. A total number of 1,557 episodes of AKI were record during the study period, of them, the estimated total number of drug-induced AKIs was 593 [95% confidence interval (CI): 485\u2013702], and the estimated prevalence was 38.1% [95%CI: 35.67\u201340.50]. The prevalences of HA-AKIs and CA-AKIs were similar (39.4% [36.24\u201342.54] and 37.4% [33.67\u201341.21], respectively). Only 6.1% of the drug-induced AKIs were recorded in the FPVD, and the proportions of recorded HA-AKIs and CA-AKI differed markedly (3.0% vs. 10.5%, respectively). One of the most frequently involved drug classes were antibiotics in the HA-AKI subgroup (13.0%) and antineoplastics in the CA-AKI subgroup (8.3%). Application of the capture-recapture method to two incomplete data sources can improve the ability to identify and quantify adverse drug reactions like AKIs. The frequency of drug-induced AKI is relatively high and is probably underestimated. The clinical management of an AKI might depend on where it originated.<\/jats:p>","DOI":"10.3389\/fphar.2022.899164","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T07:54:07Z","timestamp":1657007647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases"],"prefix":"10.3389","volume":"13","author":[{"given":"Amayelle","family":"Rey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Moragny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1001\/jama.288.13.1588","article-title":"Rates of Spontaneous Reporting of Adverse Drug Reactions in France","volume":"288","author":"B\u00e9gaud","year":"2002","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.23876\/j.krcp.2017.36.4.387","article-title":"Acute Kidney Injury Aggravated by Treatment Initiation with Apixaban: Another Twist of Anticoagulant-Related Nephropathy","volume":"36","author":"Brodsky","year":"2017","journal-title":"Kidney Res. Clin. Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/pds.4694","article-title":"Pharmacoepidemiology and Drug Safety's Special Issue on Validation Studies","volume":"28","author":"Chun","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/jac\/dks030","article-title":"Acute Kidney Injury Associated with Trimethoprim\/sulfamethoxazole","volume":"67","author":"Fraser","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B6","first-page":"219","article-title":"The Capture-Recapture Applied to Epidemiology: Principles, Limits and Application","volume":"50","author":"Gallay","year":"2002","journal-title":"Rev. Epidemiol. Sante Publique"},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.12861\/jrip.2015.12","article-title":"Drug-induced Renal Disorders","volume":"4","author":"Ghane Shahrbaf","year":"2015","journal-title":"J. Ren. Inj. Prev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/ijms20123011","article-title":"Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury","volume":"20","author":"Holditch","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/sj.ki.5002297","article-title":"Community-based Incidence of Acute Renal Failure","volume":"72","author":"Hsu","year":"2007","journal-title":"Kidney Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ccc.2015.06.005","article-title":"Drug-Induced Acute Kidney Injury: A Focus on Risk Assessment for Prevention","volume":"31","author":"Kane-Gill","year":"2015","journal-title":"Crit. Care Clin."},{"key":"B11","first-page":"169","article-title":"Drug-induced Nephrotoxicity and Medicinal Plants","volume":"11","author":"Khajavi Rad","year":"2017","journal-title":"Iran. J. Kidney Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000510455","article-title":"Drug-Induced Hospital-Acquired Acute Kidney Injury in China: A Multicenter Cross-Sectional Survey","author":"Liu","year":"2020","journal-title":"Kidney Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2125.2006.02633.x","article-title":"Using a Capture-Recapture Method to Assess the Frequency of Adverse Drug Reactions in a French University Hospital","volume":"62","author":"Lugardon","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2125.2012.04185.x","article-title":"Trends of Reporting of \u2018serious\u2019vs. \u2018non-Serious\u2019 Adverse Drug Reactions over Time: A Study in the French PharmacoVigilance Database: Short Report","volume":"74","author":"Moulis","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A Method for Estimating the Probability of Adverse Drug Reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2515\/therapie:2005005","article-title":"Validation d'une \u00e9chelle de mesure : exemple de l'\u00e9chelle fran\u00e7aise d'\u00e9vitabilit\u00e9 des effets ind\u00e9sirables m\u00e9dicamenteux","volume":"60","author":"Olivier","year":"2005","journal-title":"Therapies"},{"key":"B17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/bcp.14405","article-title":"Hospital Databases for the Identification of Adverse Drug Reactions: A 2-year Multicentre Study in 9 French General Hospitals","volume":"87","author":"Osmont","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/bcp.13216","article-title":"The Drugs that Mostly Frequently Induce Acute Kidney Injury: a Case - Noncase Study of a Pharmacovigilance Database","volume":"83","author":"Pierson-Marchandise","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B19","volume-title":"R: A Language and Environment for Statistical Computing","year":"2020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s40620-021-01174-z","article-title":"Use of a Hospital Administrative Database to Identify and Characterize Community-Acquired, Hospital-Acquired and Drug-Induced Acute Kidney Injury","volume":"35","author":"Rey","year":"2021","journal-title":"J. Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2147\/CIA.S217567","article-title":"Community-Acquired Acute Kidney Injury Induced by Drugs in Older Patients: A Multifactorial Event","volume":"14","author":"Robert","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/jcm10020168","article-title":"Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method","volume":"10","author":"Rolland","year":"2021","journal-title":"Jcm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.ajkd.2016.10.034","article-title":"Community-Acquired Acute Kidney Injury: A Nationwide Survey in China","volume":"69","author":"Wang","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1389200218666171108154419","article-title":"Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies","volume":"19","author":"Wu","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1016\/j.jacc.2017.09.1087","article-title":"Renal Outcomes in Anticoagulated Patients with Atrial Fibrillation","volume":"70","author":"Yao","year":"2017","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.899164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T07:54:13Z","timestamp":1657007653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.899164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":25,"alternative-id":["10.3389\/fphar.2022.899164"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.899164","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"article-number":"899164"}}